Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Oric Pharmaceuticals, Inc. Common Stock | ORIC

AI Analysis of Oric Pharmaceuticals, Inc. Common Stock

Wow, investors are pouring money into ORIC today, it's up by 11.11 percent. The outlook is pretty good in terms of the future earning power of the company as well as the prospects for the industry.

Currently ORIC isn't at a clear support/resistance line that seems tradable. Oric Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. It may keep moving up to $10.86 and hit some selling pressure. Hard to say though...


Last analyzed on 2026-07-23

Companies with the highest correlation to Oric Pharmaceuticals

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
RVMD | Revolution Medicines, Inc0.570.254.903.9334.6460.87408.4147294.58152.56269.79-489.60-41646.84006.87723

Top 3 correlating companies

See full charts for all peers

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-